{"transactions":[{"id":3262241,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":151554,"kind":"person","name":"Kavanaugh William Michael","position":1,"cik":"0001578767","reported_name":"Kavanaugh William Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO, Head Res.&Non-Clin. Dev."}}],"security":"Stock Option (right to buy)","published_at":"2020-02-19T23:41:18.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from January 1, 2020 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":120000,"derivative":{"exercise_price":7.13,"expiration_date":"2030-02-13","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001567619-20-004348","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761920004348/doc1.xml","form_type":"4"}},{"id":3683580,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":151554,"kind":"person","name":"Kavanaugh William Michael","position":1,"cik":"0001578767","reported_name":"Kavanaugh William Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO, Head Res.&Non-Clin. Dev."}}],"security":"Stock Option (right to buy)","published_at":"2019-01-30T00:01:25.000Z","date":"2019-01-25","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from January 1, 2019 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":90000,"derivative":{"exercise_price":16.85,"expiration_date":"2029-01-24","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001567619-19-001866","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761919001866/doc1.xml","form_type":"4"}},{"id":4087928,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":151554,"kind":"person","name":"Kavanaugh William Michael","position":1,"cik":"0001578767","reported_name":"Kavanaugh William Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO, Head Res.&Non-Clin. Dev."}}],"security":"Stock Option (right to buy)","published_at":"2018-01-26T19:54:13.000Z","date":"2018-01-24","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from January 1, 2018 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":75000,"derivative":{"exercise_price":25.82,"expiration_date":"2028-01-23","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001140361-18-003375","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118003375/doc1.xml","form_type":"4"}},{"id":4134510,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":151554,"kind":"person","name":"Kavanaugh William Michael","position":1,"cik":"0001578767","reported_name":"Kavanaugh William Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO, Head Res.&Non-Clin. Dev."}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-12T19:35:46.000Z","date":"2017-12-08","kind":"exercise","acquired":false,"shares":5130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests 25% on January 9, 2016, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, with each additional installment vesting on the last day of the month."}],"balance_after":240912,"derivative":{"exercise_price":1.5749,"expiration_date":"2025-02-08","underlying":"Common Stock","underlying_shares":5130},"source":{"system":"sec-edgar","filing":"0001140361-17-045842","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036117045842/doc1.xml","form_type":"4"}},{"id":4134509,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":151554,"kind":"person","name":"Kavanaugh William Michael","position":1,"cik":"0001578767","reported_name":"Kavanaugh William Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO, Head Res.&Non-Clin. Dev."}}],"security":"Common Stock","published_at":"2017-12-12T19:35:46.000Z","date":"2017-12-08","kind":"exercise","acquired":true,"shares":5130,"price":1.5749,"value":8079.237,"ownership":{"direct":true},"balance_after":19047,"source":{"system":"sec-edgar","filing":"0001140361-17-045842","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036117045842/doc1.xml","form_type":"4"}},{"id":4190108,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":151554,"kind":"person","name":"Kavanaugh William Michael","position":1,"cik":"0001578767","reported_name":"Kavanaugh William Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO, Head Res.&Non-Clin. Dev."}}],"security":"Stock Option (Right to Buy)","published_at":"2017-10-06T16:20:25.000Z","date":"2017-10-04","kind":"exercise","acquired":false,"shares":48368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":48368,"derivative":{"exercise_price":4.4728,"expiration_date":"2025-05-06","underlying":"Common Stock","underlying_shares":48368},"source":{"system":"sec-edgar","filing":"0001140361-17-037761","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036117037761/doc1.xml","form_type":"4"}},{"id":4190107,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":151554,"kind":"person","name":"Kavanaugh William Michael","position":1,"cik":"0001578767","reported_name":"Kavanaugh William Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO, Head Res.&Non-Clin. Dev."}}],"security":"Common Stock","published_at":"2017-10-06T16:20:25.000Z","date":"2017-10-04","kind":"sale","acquired":false,"shares":48368,"price":24.34,"value":1177277.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":13917,"source":{"system":"sec-edgar","filing":"0001140361-17-037761","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036117037761/doc1.xml","form_type":"4"}},{"id":4190106,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":151554,"kind":"person","name":"Kavanaugh William Michael","position":1,"cik":"0001578767","reported_name":"Kavanaugh William Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO, Head Res.&Non-Clin. Dev."}}],"security":"Common Stok","published_at":"2017-10-06T16:20:25.000Z","date":"2017-10-04","kind":"exercise","acquired":true,"shares":48368,"price":4.4728,"value":216340.3904,"ownership":{"direct":true},"balance_after":62285,"source":{"system":"sec-edgar","filing":"0001140361-17-037761","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036117037761/doc1.xml","form_type":"4"}},{"id":4351349,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":151554,"kind":"person","name":"Kavanaugh William Michael","position":1,"cik":"0001578767","reported_name":"Kavanaugh William Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO, Head Res.&Non-Clin. Dev."}}],"security":"Stock Option (Right to Buy)","published_at":"2017-04-17T22:25:21.000Z","date":"2017-04-14","kind":"grant","acquired":true,"shares":48368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 7, 2015, the Reporting Person was granted an option to purchase 96,736 shares of Common Stock, as adjusted for the 1-for-62.997 reverse stock split effected prior to the Issuer's initial public offering, to vest in two equal tranches upon achievement of certain performance-based milestones (the \"Performance Option\"). On September 26, 2016, the first performance milestone was achieved resulting in 50% of the Performance Option vesting. On April 14, 2017, the second performance milestone was achieved resulting in the remaining 50% of the Performance Option vesting."}],"balance_after":96736,"derivative":{"exercise_price":4.4728,"expiration_date":"2025-05-06","underlying":"Common Stock","underlying_shares":48368},"source":{"system":"sec-edgar","filing":"0001140361-17-016029","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036117016029/doc1.xml","form_type":"4"}},{"id":4478847,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":151554,"kind":"person","name":"Kavanaugh William Michael","position":1,"cik":"0001578767","reported_name":"Kavanaugh William Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO, Head Res.&Non-Clin. Dev."}}],"security":"Stock Option (right to buy)","published_at":"2017-01-27T18:53:24.000Z","date":"2017-01-25","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from January 1, 2017 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":120000,"derivative":{"exercise_price":11.94,"expiration_date":"2027-01-24","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001140361-17-003158","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036117003158/doc1.xml","form_type":"4"}},{"id":4593134,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":151554,"kind":"person","name":"Kavanaugh William Michael","position":1,"cik":"0001578767","reported_name":"Kavanaugh William Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO, Head Res.&Non-Clin. Dev."}}],"security":"Stock Option (Right to Buy)","published_at":"2016-09-28T23:12:53.000Z","date":"2016-09-26","kind":"grant","acquired":true,"shares":48368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 7, 2015, the Reporting Person was granted an option to purchase 96,736 shares of Common Stock, as adjusted for the 1-for-62.997 reverse stock split effected prior to the Issuer's initial public offering, to vest in two equal tranches upon achievement of certain performance-based milestones (the \"Performance Option\"). On September 26, 2016, the first performance milestone was achieved resulting in 50% of the Performance Option vesting."}],"balance_after":48368,"derivative":{"exercise_price":4.4728,"expiration_date":"2025-05-06","underlying":"Common Stock","underlying_shares":48368},"source":{"system":"sec-edgar","filing":"0001140361-16-080947","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036116080947/doc1.xml","form_type":"4"}}]}